BIOCANCELL THERAPEUTICS INC. 4
4 · BIOCANCELL THERAPEUTICS INC. · Filed Aug 3, 2009
Insider Transaction Report
Form 4
BIOCANCELL THERAPEUTICS INC.BICL.TA
Hochberg Abraham
DirectorChief Scientist10% Owner
Transactions
- Award
Employee Options
2008-12-03+90,000→ 120,000 totalExercise: $0.60Exp: 2018-12-03→ Common Stock, par value $0.01 (90,000 underlying)
Footnotes (1)
- [F1](1) 10,000 options shall vest and be exercisable at the end of each calendar quarter, September 30, 2009 until September 30, 2011. The Reporting Person was granted the option on December 3, 2008, and reported the initial vested amount under the option on his Form 3 filed with the SEC on June 29, 2009. The Reporting Person is filing this Form 4 to report the remaining securities under the option.